Viewing Study NCT06431750


Ignite Creation Date: 2025-12-24 @ 5:01 PM
Ignite Modification Date: 2026-01-07 @ 4:04 AM
Study NCT ID: NCT06431750
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-01-14
First Post: 2024-04-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Prospective Observational Study to Evaluate Secukinumab Treatment Effectiveness in Pediatric Patients With Active Juvenile Enthesitis-related or Psoriatic Arthritis
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module